EGFR, P53, IDH-1 and MDM2 Immunohistochemical Analysis in Glioblastoma: Therapeutic and Prognostic Correlation

Arquivos de Neuro-Psiquiatria - Brazil
doi 10.1590/0004-282x20150059
Full Text
Abstract

Available in full text

Date
Authors
Publisher

FapUNIFESP (SciELO)

Related search

EGFR and mTOR as Therapeutic Targets in Glioblastoma

Oncotarget
Oncology
2019English

Prognostic Significance of IDH-1 and MGMT in Patients With Glioblastoma: One Step Forward, and One Step Back?

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2011English

Current Therapeutic Advances Targeting EGFR and EGFRvIII in Glioblastoma

Frontiers in Oncology
Cancer ResearchOncology
2015English

The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma

Frontiers in Oncology
Cancer ResearchOncology
2019English

HDMX Stabilizes Mdm2 and P53

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2000English

P53-Independent Role of MDM2 in TGF- 1 Resistance

Science
MultidisciplinaryPhilosophy of ScienceHistory
1998English

Immunohistochemical Over Expression of P53 in Head and Neck Squamous Cell Carcinoma: Clinical and Prognostic Significance

BMC Research Notes
BiochemistryMedicineGeneticsMolecular Biology
2018English

EGFR and PTEN Gene Mutation Status in Glioblastoma Patients and Their Prognostic Impact on Patient's Survival

Journal of Carcinogenesis & Mutagenesis
2015English

IDH Mutation Analysis in Glioma Patients by CADMA Compared With SNaPshot Assay and Two Immunohistochemical Methods

Pathology and Oncology Research
MedicineForensic MedicinePathologyOncologyCancer Research
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy